Grimes & Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $761K | Buy |
7,354
+20
| +0.3% | +$1.78K | 0.02% | 282 |
|
|
2026
Q1 | $527K | Sell |
7,334
-12,294
| -63% | -$947K | 0.01% | 300 |
|
|
2025
Q4 | $1.56M | Buy |
19,628
+2,492
| +15% | +$196K | 0.04% | 211 |
|
|
2025
Q3 | $1.29M | Buy |
17,136
+7,599
| +80% | +$521K | 0.03% | 216 |
|
|
2025
Q2 | $658K | Buy |
9,537
+519
| +6% | +$34K | 0.02% | 241 |
|
|
2025
Q1 | $611K | Sell |
9,018
-1,023
| -10% | -$61.2K | 0.02% | 222 |
|
|
2024
Q4 | $451K | Sell |
10,041
-260,312
| -96% | -$14.6M | 0.01% | 260 |
|
|
2024
Q3 | $17M | Sell |
270,353
-783
| -0.3% | -$45.7K | 0.46% | 47 |
|
|
2024
Q2 | $16M | Buy |
271,136
+6,793
| +3% | +$425K | 0.48% | 47 |
|
|
2024
Q1 | $21.1M | Buy |
264,343
+8,514
| +3% | +$650K | 0.65% | 38 |
|
|
2023
Q4 | $20.2M | Buy |
255,829
+7,344
| +3% | +$523K | 0.67% | 32 |
|
|
2023
Q3 | $17.3M | Buy |
248,485
+7,545
| +3% | +$535K | 0.67% | 32 |
|
|
2023
Q2 | $16.7M | Buy |
240,940
+34,293
| +17% | +$2.44M | 0.59% | 38 |
|
|
2023
Q1 | $15.4M | Buy |
206,647
+134,493
| +186% | +$11.3M | 0.63% | 35 |
|
|
2022
Q4 | $6.72M | Buy |
72,154
+5,259
| +8% | +$507K | 0.28% | 71 |
|
|
2022
Q3 | $6.38M | Buy |
66,895
+2,330
| +4% | +$231K | 0.33% | 65 |
|
|
2022
Q2 | $5.98M | Buy |
64,565
+748
| +1% | +$73K | 0.3% | 69 |
|
|
2022
Q1 | $6.46M | Sell |
63,817
-671
| -1% | -$70.5K | 0.34% | 74 |
|
|
2021
Q4 | $6.65M | Buy |
64,488
+354
| +0.6% | +$32.7K | 0.3% | 73 |
|
|
2021
Q3 | $5.44M | Sell |
64,134
-110,209
| -63% | -$9.23M | 0.24% | 83 |
|
|
2021
Q2 | $14.5M | Buy |
174,343
+4,280
| +3% | +$350K | 0.63% | 43 |
|
|
2021
Q1 | $12.8M | Buy |
170,063
+4,374
| +3% | +$319K | 0.62% | 44 |
|
|
2020
Q4 | $11.3M | Sell |
165,689
-408
| -0.2% | -$26.5K | 0.59% | 47 |
|
|
2020
Q3 | $9.7M | Buy |
166,097
+26,124
| +19% | +$1.63M | 0.62% | 47 |
|
|
2020
Q2 | $9.09M | Buy |
139,973
+2,269
| +2% | +$143K | 0.63% | 48 |
|
|
2020
Q1 | $8.17M | Buy |
137,704
+3,956
| +3% | +$264K | 0.75% | 31 |
|
|
2019
Q4 | $9.94M | Sell |
133,748
-639
| -0.5% | -$44.9K | 0.65% | 40 |
|
|
2019
Q3 | $8.48M | Buy |
134,387
+4,084
| +3% | +$242K | 0.6% | 44 |
|
|
2019
Q2 | $7.1M | Buy |
130,303
+9,343
| +8% | +$503K | 0.54% | 58 |
|
|
2019
Q1 | $6.52M | Buy |
120,960
+13,780
| +13% | +$851K | 0.51% | 61 |
|
|
2018
Q4 | $7.02M | Sell |
107,180
-4,847
| -4% | -$362K | 0.69% | 39 |
|
|
2018
Q3 | $8.82M | Buy |
112,027
+4,875
| +5% | +$349K | 0.71% | 41 |
|
|
2018
Q2 | $6.89M | Sell |
107,152
-31
| -0% | -$2.04K | 0.61% | 54 |
|
|
2018
Q1 | $6.67M | Buy |
107,183
+6,584
| +7% | +$472K | 0.65% | 50 |
|
|
2017
Q4 | $7.29M | Buy |
100,599
+1,453
| +1% | +$106K | 0.7% | 41 |
|
|
2017
Q3 | $8.06M | Sell |
99,146
-302
| -0.3% | -$23.9K | 0.86% | 37 |
|
|
2017
Q2 | $8M | Sell |
99,448
-213
| -0.2% | -$16.8K | 0.89% | 36 |
|
|
2017
Q1 | $7.82M | Buy |
99,661
+2,509
| +3% | +$200K | 0.86% | 32 |
|
|
2016
Q4 | $7.67M | Buy |
97,152
+94,516
| +3,586% | +$7.65M | 0.89% | 30 |
|
|
2016
Q3 | $235K | Buy |
2,636
+100
| +4% | +$9.44K | 0.03% | 177 |
|
|
2016
Q2 | $243K | Buy |
+2,536
| New | +$253K | 0.03% | 176 |
|
Other funds holding CVS
Grimes & Company's CVS Position: Q2 2026 in Review
Grimes & Company increased its CVS Health (CVS) stake by 0.27% in Q2 2026, buying an estimated $1.78K and bringing the position to 7,354 shares worth $761K. The position accounts for 0.02% of the portfolio, ranked #282.
Grimes & Company first reported a position in CVS in Q2 2016 and has held it in 41 quarters since. The position peaked at $21.1M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Grimes & Company held 7,354 shares of CVS Health worth $761K as of Q2 2026.
- Grimes & Company bought 20 CVS Health shares in Q2 2026, an estimated $1.78K.
- CVS Health made up 0.02% of Grimes & Company's portfolio in Q2 2026, its #282 holding.
- Grimes & Company first reported a position in CVS Health in Q2 2016 and has held it in 41 quarters since.
- Grimes & Company's CVS Health position peaked at $21.1M in Q1 2024.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.